ADDvise Group B (ADDV-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ADDvise Group B (ADDV-B) has a cash flow conversion efficiency ratio of 0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr35.30 Million ≈ $3.80 Million USD) by net assets (Skr1.11 Billion ≈ $119.32 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View latest ADDvise Group B stock price today for real-time trading data and today's change.
ADDvise Group B - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how ADDvise Group B's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see how much is ADDvise Group B worth for the company's overall valuation and market capitalisation.
ADDvise Group B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ADDvise Group B ranked by their cash flow conversion efficiency. Also see ADDV-B current and non-current assets for a full breakdown of the balance sheet.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chainqui Construction Development Co Ltd
TW:2509
|
-0.053x |
|
Kontrolmatik Teknoloji Enerji ve Mu
IS:KONTR
|
0.475x |
|
Kamdhenu Limited
NSE:KAMDHENU
|
0.035x |
|
WRKR Ltd
AU:WRK
|
0.002x |
|
Ultralife Corporation
NASDAQ:ULBI
|
0.009x |
|
Iceland Seafood International hf.
IC:ICESEA
|
0.051x |
|
Pha Lai Thermal Power JSC
VN:PPC
|
-0.075x |
|
Devyser Diagnostics AB
ST:DVYSR
|
0.034x |
Annual Cash Flow Conversion Efficiency for ADDvise Group B (2007–2024)
The table below shows the annual cash flow conversion efficiency of ADDvise Group B from 2007 to 2024. Review ADDV-B financial flexibility score to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr835.00 Million ≈ $89.86 Million |
Skr61.70 Million ≈ $6.64 Million |
0.074x | -74.11% |
| 2023-12-31 | Skr613.20 Million ≈ $65.99 Million |
Skr175.00 Million ≈ $18.83 Million |
0.285x | +28.02% |
| 2022-12-31 | Skr492.87 Million ≈ $53.04 Million |
Skr109.88 Million ≈ $11.82 Million |
0.223x | +441.19% |
| 2021-12-31 | Skr247.28 Million ≈ $26.61 Million |
Skr10.19 Million ≈ $1.10 Million |
0.041x | -93.47% |
| 2020-12-31 | Skr91.05 Million ≈ $9.80 Million |
Skr57.44 Million ≈ $6.18 Million |
0.631x | +374.49% |
| 2019-12-31 | Skr84.14 Million ≈ $9.06 Million |
Skr11.19 Million ≈ $1.20 Million |
0.133x | +11291.93% |
| 2018-12-31 | Skr51.41 Million ≈ $5.53 Million |
Skr60.00K ≈ $6.46K |
0.001x | +100.31% |
| 2017-12-31 | Skr49.01 Million ≈ $5.27 Million |
Skr-18.74 Million ≈ $-2.02 Million |
-0.382x | +47.19% |
| 2016-12-31 | Skr46.04 Million ≈ $4.96 Million |
Skr-33.34 Million ≈ $-3.59 Million |
-0.724x | +18.40% |
| 2015-12-31 | Skr4.25 Million ≈ $457.58K |
Skr-3.77 Million ≈ $-406.04K |
-0.887x | -53.54% |
| 2014-12-31 | Skr14.88 Million ≈ $1.60 Million |
Skr-8.60 Million ≈ $-925.39K |
-0.578x | -3.43% |
| 2013-12-31 | Skr11.07 Million ≈ $1.19 Million |
Skr-6.19 Million ≈ $-665.93K |
-0.559x | -172.72% |
| 2012-12-31 | Skr9.65 Million ≈ $1.04 Million |
Skr7.41 Million ≈ $797.76K |
0.768x | +529.10% |
| 2011-12-31 | Skr9.24 Million ≈ $994.69K |
Skr1.13 Million ≈ $121.50K |
0.122x | +120.24% |
| 2010-12-31 | Skr4.30 Million ≈ $463.29K |
Skr-2.60 Million ≈ $-279.59K |
-0.603x | -556.84% |
| 2008-12-31 | Skr2.32 Million ≈ $250.10K |
Skr307.00K ≈ $33.04K |
0.132x | -69.16% |
| 2007-12-31 | Skr3.30 Million ≈ $354.70K |
Skr1.41 Million ≈ $151.95K |
0.428x | -- |
About ADDvise Group B
ADDvise Group AB (publ) supplies medical devices, equipment, and consumables to public and private laboratories and research facilities, healthcare, and pharmaceuticals in North America, Europe, South America, Sweden, and internationally. The company provides laboratory furniture, protective ventilation systems, climate-controlled clean rooms, and laboratory equipment; and develops and supplies m… Read more